Literature DB >> 2846493

Characterization of beta-adrenergic receptors in cultured human and bovine endothelial cells.

R E Howell1, S M Albelda, M L Daise, E M Levine.   

Abstract

We used radioligand binding methods to characterize beta-adrenergic receptors on endothelial cells cultured from adult human iliac vein (HIVE) and bovine fetal aorta (BFAE). For comparison, we also studied the well-characterized C6 glioma cell line (C6). Both human and bovine endothelial cells showed specific saturable binding of [125I]iodopindolol. There was no difference in the binding affinity (KD) of iodopindolol to membranes from the three cell types. However, the beta-receptor density (Bmax) was greater on HIVE cells and BFAE cells than on C6 cells. Displacement of ligand from HIVE and BFAE cells by zinterol or from BFAE cells by ICI 89,406 was consistent with binding to the beta 2-subtype. In contrast, displacement of ligand from C6 cells by zinterol or ICI 89,406 was consistent with binding to both beta 1- and beta 2-subtypes. Exposing BFAE cells in culture to 10 microM isoproterenol for 6 h resulted in a 55% decrease in Bmax without a change in KD. We conclude that 1) human and bovine endothelial cells in culture contain a substantial population of beta-adrenergic receptors, which are predominantly of the beta 2-subtype, and 2) endothelial beta-receptors exhibit downregulation by beta-agonists in culture.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846493     DOI: 10.1152/jappl.1988.65.3.1251

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  15 in total

1.  Norepinephrine and adenosine-5'-triphosphate synergize in inducing IL-6 production by human dermal microvascular endothelial cells.

Authors:  Lori L Stohl; Julie B Zang; Wanhong Ding; Michela Manni; Xi K Zhou; Richard D Granstein
Journal:  Cytokine       Date:  2013-09-08       Impact factor: 3.861

2.  Regulation of T helper cell responses during antigen presentation by norepinephrine-exposed endothelial cells.

Authors:  Linghui Xu; Wanhong Ding; Lori L Stohl; Xi K Zhou; Shayan Azizi; Ethan Chuang; Jimmy Lam; John A Wagner; Richard D Granstein
Journal:  Immunology       Date:  2017-12-20       Impact factor: 7.397

3.  Contribution of nitric oxide to beta2-adrenoceptor mediated vasodilatation in human forearm arterial vasculature.

Authors:  N G Majmudar; D Anumba; S C Robson; G A Ford
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

4.  Nitric oxide synthase and cyclooxygenase modulate β-adrenergic cutaneous vasodilatation and sweating in young men.

Authors:  Naoto Fujii; Brendan D McNeely; Glen P Kenny
Journal:  J Physiol       Date:  2016-12-12       Impact factor: 5.182

5.  Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro.

Authors:  A Ferro; L R Queen; R M Priest; B Xu; J M Ritter; L Poston; J P Ward
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

6.  Nitric oxide-dependent vasodilatation of rabbit femoral artery by beta(2)-adrenergic stimulation or cyclic AMP elevation in vivo.

Authors:  B Xu; J Li; L Gao; A Ferro
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

7.  Beta-adrenoceptors in human alveolar macrophages isolated by elutriation.

Authors:  P Hjemdahl; K Larsson; M C Johansson; A Zetterlund; A Eklund
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

8.  Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.

Authors:  Albert Ferro; Marcy Coash; Takahiro Yamamoto; Jubli Rob; Yong Ji; Lindsay Queen
Journal:  Br J Pharmacol       Date:  2004-09-06       Impact factor: 8.739

9.  Effect of theophylline on beta-adrenergic receptor density and cAMP content in bovine aortic smooth muscle cells.

Authors:  K Graf; U Dümmler; M Grfe; A O'Connor; E Fleck; G Kunkel
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

10.  β Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves β2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia.

Authors:  Alessandro Cannavo; Daniela Liccardo; Anastasios Lymperopoulos; Giuseppina Gambino; Maria Loreta D'Amico; Franco Rengo; Walter J Koch; Dario Leosco; Nicola Ferrara; Giuseppe Rengo
Journal:  J Pharmacol Exp Ther       Date:  2015-11-24       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.